These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Augmentation and combination strategies for complicated depression. Fava M J Clin Psychiatry; 2009 Nov; 70(11):e40. PubMed ID: 20031088 [TBL] [Abstract][Full Text] [Related]
13. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation. Edwards SJ; Hamilton V; Nherera L; Trevor N Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258 [TBL] [Abstract][Full Text] [Related]
14. What role do atypical antipsychotic drugs have in treatment-resistant depression? Thase ME J Clin Psychiatry; 2002 Feb; 63(2):95-103. PubMed ID: 11874227 [TBL] [Abstract][Full Text] [Related]
15. Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. Hirschfeld RM; Montgomery SA; Aguglia E; Amore M; Delgado PL; Gastpar M; Hawley C; Kasper S; Linden M; Massana J; Mendlewicz J; Möller HJ; Nemeroff CB; Saiz J; Such P; Torta R; Versiani M J Clin Psychiatry; 2002 Sep; 63(9):826-37. PubMed ID: 12363125 [TBL] [Abstract][Full Text] [Related]
19. The use of antidepressants in novel combination therapies. Shelton RC J Clin Psychiatry; 2003; 64 Suppl 2():14-8. PubMed ID: 12625794 [TBL] [Abstract][Full Text] [Related]
20. The need for clinically relevant research on treatment-resistant depression. Thase ME J Clin Psychiatry; 2001 Apr; 62(4):221-4. PubMed ID: 11379833 [No Abstract] [Full Text] [Related] [Next] [New Search]